Unity Biotechnology, Inc.: UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidenc ...
Sarajevo Times13h
Heartwarming Unity: Catholic Priest in BiH Hosts Iftar for Bosniak Neighbors
In the village of Scipe, near Prozor in Bosnia and Herzegovina (BiH), priest Branko Juric organized an iftar for his Bosniak neighbors. This uncommon example of interfaith solidarity, held in the ...
The Manila Times13h
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
UNITY anticipates the complete 36-week data results of the remaining patients in the second quarter of 2025.
The Citizen21h
A celebration of courage, community, and swimming success at Unity College
Unity College’s annual swimming gala showcased not only remarkable swimming skills but also the spirit of participation and community, leaving every participant feeling like a champion.